| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
53,903 |
42,387 |
$2.92M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
27,304 |
20,759 |
$1.87M |
| 99199 |
Unlisted special service, procedure or report |
187,586 |
113,400 |
$1.12M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
7,171 |
6,007 |
$589K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,488 |
4,713 |
$483K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
9,026 |
7,539 |
$273K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
15,408 |
12,621 |
$258K |
| 99051 |
|
12,591 |
10,187 |
$247K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,379 |
2,061 |
$211K |
| 87428 |
|
3,511 |
2,955 |
$173K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
6,459 |
5,092 |
$160K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,035 |
4,248 |
$156K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
10,150 |
6,769 |
$143K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,431 |
1,930 |
$130K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,209 |
1,977 |
$106K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
7,924 |
6,819 |
$70K |
| 87634 |
|
1,554 |
1,192 |
$41K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
391 |
351 |
$39K |
| 90474 |
|
1,992 |
1,641 |
$36K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,654 |
1,084 |
$21K |
| 92551 |
|
6,979 |
5,864 |
$17K |
| 87631 |
|
239 |
185 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,085 |
1,028 |
$14K |
| 99493 |
|
85 |
79 |
$12K |
| 90670 |
|
4,602 |
3,881 |
$12K |
| 99460 |
|
154 |
121 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
5,321 |
4,307 |
$10K |
| 99173 |
|
8,385 |
7,039 |
$8K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
183 |
138 |
$8K |
| 90473 |
|
720 |
481 |
$7K |
| 90688 |
|
2,880 |
2,182 |
$7K |
| 99401 |
|
223 |
154 |
$4K |
| 90686 |
|
1,311 |
1,165 |
$4K |
| 81002 |
|
1,652 |
1,358 |
$4K |
| 80053 |
Comprehensive metabolic panel |
562 |
448 |
$3K |
| 90723 |
|
1,771 |
1,606 |
$3K |
| 90648 |
|
2,496 |
2,216 |
$3K |
| 90680 |
|
2,108 |
1,750 |
$3K |
| 90677 |
|
737 |
671 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
29 |
12 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
19 |
16 |
$2K |
| 90697 |
|
1,334 |
1,101 |
$2K |
| 90710 |
|
531 |
466 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
185 |
142 |
$2K |
| 90651 |
|
64 |
53 |
$1K |
| 90656 |
|
361 |
335 |
$1K |
| 90672 |
|
807 |
535 |
$1K |
| 80061 |
Lipid panel |
163 |
130 |
$1K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
18 |
13 |
$1K |
| 90633 |
|
863 |
728 |
$1K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
233 |
168 |
$989.07 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
61 |
31 |
$861.66 |
| 71046 |
Radiologic examination, chest; 2 views |
47 |
40 |
$809.95 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
455 |
300 |
$747.74 |
| 90734 |
|
29 |
28 |
$631.30 |
| 90620 |
|
18 |
12 |
$619.68 |
| 0001A |
|
21 |
12 |
$600.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
82 |
66 |
$519.89 |
| 99050 |
|
17 |
14 |
$333.60 |
| 99490 |
Ccm add 20min |
15 |
15 |
$260.76 |
| 90715 |
|
70 |
57 |
$256.48 |
| 90619 |
|
104 |
84 |
$229.05 |
| 90696 |
|
102 |
90 |
$193.71 |
| 96127 |
|
84 |
50 |
$152.41 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
28 |
15 |
$132.24 |
| 90647 |
|
108 |
105 |
$113.85 |
| 3078F |
|
579 |
469 |
$100.00 |
| 3074F |
|
562 |
456 |
$75.00 |
| 90681 |
|
201 |
196 |
$67.65 |
| 90707 |
|
15 |
15 |
$36.00 |
| 90660 |
|
69 |
58 |
$33.00 |
| 90700 |
|
56 |
52 |
$22.55 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
32 |
18 |
$12.25 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
32 |
18 |
$12.25 |
| 90716 |
|
27 |
27 |
$11.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
94 |
88 |
$7.79 |
| 90381 |
|
26 |
15 |
$6.94 |
| 1160F |
|
17 |
15 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
818 |
686 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
33 |
12 |
$0.00 |
| 91307 |
|
27 |
14 |
$0.00 |
| G2181 |
Bmi not documented due to medical reason or patient refusal of height or weight measurement |
17 |
16 |
$0.00 |
| 3079F |
|
20 |
13 |
$0.00 |